Treatment Options for Tinea Versicolor with Elevated LFTs

Rationale for Topical Treatment

Topical ketoconazole formulations do not have significant systemic absorption when applied to intact skin, making them safe options for patients with elevated LFTs 1
Oral ketoconazole has been associated with hepatotoxicity in 10-20% of patients, with the FDA issuing a black box warning regarding its potential for serious liver damage 2
Hepatotoxicity from oral ketoconazole typically appears within the first 6 months of treatment and may not be dose-dependent 2

Miconazole cream and Clotrimazole cream are alternative topical options if ketoconazole cream is not available or not tolerated, as recommended by the Centers for Disease Control and Prevention 3

Oral ketoconazole should be avoided due to the patient's elevated LFTs and previous poor response to oral fluconazole, as advised by the American Academy of Dermatology 2
The FDA has restricted oral ketoconazole use due to risk of hepatotoxicity, which has been estimated to occur in 1:10,000 to 1:15,000 exposed persons, according to the Centers for Disease Control and Prevention 3
Oral itraconazole also carries a risk of hepatotoxicity and should be used with caution in patients with pre-existing liver disease, as recommended by the Infectious Diseases Society of America 4

Patients should be advised to keep skin dry, especially in hot, humid weather, wear loose-fitting, cotton clothing, apply antifungal powders containing miconazole or clotrimazole to susceptible areas, and consider discarding old footwear or treating it with antifungal powders, as recommended by the British Association of Dermatologists 5

The American Association for the Study of Liver Diseases recommends monitoring LFTs periodically if patient requires any systemic antifungal therapy in the future 2
Topical therapy is preferred for patients with liver disease due to minimal systemic absorption, as stated by the American College of Gastroenterology 1